To this end, we interrogated well-annotated datasets with rich clinical annotations to estimate whether increased N-cadherin mRNA levels is associated to disease progression in other prevalent tumors such as colorectal, breast and lung cancer. This evidence concerns the gene CDH2 and lung cancer.